Paxman AB Market Cap ($158.29 Million)
Market Cap & Net Worth: Paxman AB (PAX)
Paxman AB market cap. Paxman AB (ST:PAX) has a market capitalization of $158.29 Million (Skr1.47 Billion) as of November 5, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #17274 globally and #294 in its home market, demonstrating a -5.25% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Paxman AB's stock price Skr63.20 by its total outstanding shares 23273416 (23.27 Million). Also see Paxman AB operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Paxman AB Market Cap History (2017–2026)
Paxman AB market cap history from 2017 to 2026. Data shows growth from $48.84 Million to $158.29 Million (20.55% CAGR). Check PAX live share price for real-time trading data and today's change.
Index Memberships
Paxman AB is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
First North Sweden PI
FNSESEKPI
|
$15.32 Billion | 1.03% | #25 of 281 |
Weight: Paxman AB's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Paxman AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Paxman AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore PAX shareholders equity momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.65x
Paxman AB's market cap is 0.65 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.09x
Paxman AB's market cap is 4.09 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $48.84 Million | $31.33 Million | -$6.72 Million | 1.56x | N/A |
| 2018 | $60.36 Million | $58.02 Million | -$7.10 Million | 1.04x | N/A |
| 2019 | $150.28 Million | $85.28 Million | $2.76 Million | 1.76x | 54.53x |
| 2020 | $63.62 Million | $78.05 Million | -$19.19 Million | 0.82x | N/A |
| 2021 | $162.80 Million | $96.20 Million | -$12.78 Million | 1.69x | N/A |
| 2022 | $107.95 Million | $156.75 Million | -$10.32 Million | 0.69x | N/A |
| 2023 | $92.17 Million | $210.12 Million | $8.33 Million | 0.44x | 11.06x |
| 2024 | $164.30 Million | $253.01 Million | $40.20 Million | 0.65x | 4.09x |
Competitor Companies of PAX by Market Capitalization
Companies near Paxman AB in the global market cap rankings as of November 5, 2026. Also see total assets of Paxman AB for a full breakdown of the balance sheet.
Key companies related to Paxman AB by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #107 globally with a market cap of $196.11 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #182 globally with a market cap of $130.04 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #225 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #237 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #107 | Abbott Laboratories | NYSE:ABT | $196.11 Billion | $115.51 |
| #182 | Stryker Corporation | NYSE:SYK | $130.04 Billion | $339.65 |
| #225 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $104.96 |
| #237 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Paxman AB (2017–2026)
Market capitalization of Paxman AB from 2017 to today. Between 2017 and today, Paxman AB's market cap moved from $48.84 Million to $ 158.29 Million, with a yearly change of 20.55%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr158.29 Million | +12.46% |
| 2025 | Skr140.76 Million | -14.33% |
| 2024 | Skr164.30 Million | +78.26% |
| 2023 | Skr92.17 Million | -14.62% |
| 2022 | Skr107.95 Million | -33.69% |
| 2021 | Skr162.80 Million | +155.91% |
| 2020 | Skr63.62 Million | -57.67% |
| 2019 | Skr150.28 Million | +148.96% |
| 2018 | Skr60.36 Million | +23.59% |
| 2017 | Skr48.84 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Paxman AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $158.29 Million USD |
| MoneyControl | $158.29 Million USD |
| MarketWatch | $158.29 Million USD |
| marketcap.company | $158.29 Million USD |
| Reuters | $158.29 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Paxman AB
Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. It serves various cancer centers and hospitals. The company has collaborated with the University of Huddersfield and the University of Leeds to develop a wearable medical cooling device; and the National University Hospital of … Read more